NeOnc Technologies Holdings is trading at $3.54, up 15.31% in pre-market, with no clear company-specific catalyst identified in available coverage.

  • The prior close was $3.07.
  • On November 2, NeOnc announced that NEO100 and NEO212 data will be presented at a November 13 neuro-oncology meeting; the announcement does not establish a direct reason for the move.
  • Broader market indicators were mixed and do not clearly explain the stock’s gain.